Trials / Completed
CompletedNCT01892163
Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone
A Multicentre Prospective Open-label Randomised Clinical Trial Comparing the Efficacy of Fixed Versus PRN Dosing of 700 μg Dexamethasone Posterior Segment Drug Delivery System (Ozurdex) in Patients With Refractory Diabetic Macular Oedema
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Moorfields Eye Hospital NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre randomized controlled trial to evaluate whether 5 monthly fixed dosing of 700 µg Dexamethasone Posterior Segment Drug Delivery System (Ozurdex) is as efficacious as Optical coherence tomography (OCT)-guided PRN dosing in patients with refractory diabetic macular edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ozurdex | Dexamethasone implant (Ozurdex) |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-07-04
- Last updated
- 2017-02-23
- Results posted
- 2017-02-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01892163. Inclusion in this directory is not an endorsement.